GIDDEN-16 TABLETS

Product Overview: Gidden-16 (Betahistine Hydrochloride 16 mg)

Gidden-16 Tablets is a specialized pharmaceutical formulation manufactured by Solvista Healthcare, designed specifically for the effective management of vertigo and balance-related disorders. Each tablet contains 16 mg of Betahistine Hydrochloride I.P., a potent histamine analogue that has become a gold standard in treating vestibular system dysfunction.

Therapeutic Indications

Gidden-16 is primarily indicated for the management of Meniere’s disease and associated vestibular symptoms. The product literature identifies three core clinical symptoms it addresses:

1. Vertigo: The sensation of spinning or dizziness, often accompanied by nausea.
2. Tinnitus: A persistent ringing or buzzing in the ears.
3. Hearing Loss: Progressive or fluctuating auditory disturbances.

Additionally, it is used for general balance management and symptomatic relief of dizziness that stems from inner ear imbalances.

Mechanism of Action

The efficacy of Gidden-16 lies in its dual action on the histamine receptors ($H_1$ and $H_3$).

• Inner Ear Microcirculation: Betahistine acts as a strong $H_3$ antagonist and a weak $H_1$ agonist. By inhibiting $H_3$ receptors, it increases the release of neurotransmitters that promote vasodilation. This specifically improves blood flow (microcirculation) in the stria vascularis of the inner ear, which helps reduce endolymphatic pressure.
• Vestibular Compensation: The drug also acts on the central nervous system to accelerate vestibular compensation. This means it helps the brain adapt more quickly to imbalances caused by inner ear damage, reducing the long-term impact of vertigo episodes.

Key Clinical Benefits

As highlighted by Solvista Healthcare, Gidden-16 offers several targeted advantages:

• Reduces Vertigo Episodes: By stabilizing inner ear pressure, the frequency and severity of dizzy spells are significantly diminished.
• Relieves Tinnitus & Dizziness: It addresses the secondary symptoms of vestibular disorders, helping patients regain a sense of “quiet” and stability.
• Enhances Vestibular Compensation: It assists the body’s natural recovery process following a vestibular hit.
• Trusted Quality Manufacturing: The product is backed by high-standard certifications, including WHO-GMP (Good Manufacturing Practices) and ISO Certification, ensuring that each 16 mg tablet meets international safety and purity standards.

Dosage and Presentation

Gidden-16 is presented in a 10×15 tablet pack (150 tablets total), which is a standard bulk format for chronic management. The 16 mg dosage allows for flexible administration—typically prescribed two to three times daily depending on the severity of the patient’s condition and the physician’s recommendation.